Health Journal

  • Pushing Limits of New Knees

    Joint-replacement patients these days are younger and more active than ever before. And while implant makers are working to build longer-wearing knees and hips, many patients may not be able to resume high-impact activities.

  • FDA Heightens Painkiller Oversight

    The FDA said it will require some painkiller manufacturers to produce new educational tools in an effort to quell prescription-drug abuse.

  • Subscriber Content Read Preview

    J&J; Profit Falls; Forecast Boosted

    Johnson & Johnson's earnings fell 23%, hurt by litigation and recall-related charges, but the health-care giant's revenue received a boost from a weaker dollar and J&J; raised its full-year earnings forecast.

  • New Guidelines for Spotting Alzheimer's

    The first update in nearly 30 years to U.S. guidelines for the diagnosis of Alzheimer's disease expands the definition to include patients with earlier stage symptoms.

  • [heartbeat]

    A Giant Step for Heart Research

    Researchers are studying what happens to astronauts' hearts in space to help patients back on Earth.

  • [RESREPORT]

    Cutting Allergy Shots

    Researchers have developed a new vaccine to desensitize people with a cat allergy that is faster and safer than traditional immunotherapies.

  • [CRIB]

    When a Cuddly Crib Puts Baby in Danger

    That adorable crib may be a health hazard. Fluffy bumpers, pillows and blankets and a menagerie of stuffed animals all pose a suffocation risk to babies less than 12 months old.

  • [ACHES]

    A Good Night's Sleep by a Nose

    Snoring and waking up at night are common nighttime annoyances, but for many, they are signs of a major health problem: sleep apnea. A number of companies are marketing nasal devices to treat the disorder.

  • Subscriber Content Read Preview

    [UPSHOT]

    Weaker Dollar Aiding Sales

    U.S. drug makers Pfizer and Eli Lilly are flying against some strong headwinds, including patent expirations and government imposed price cuts. But a weaker U.S. dollar is giving a lift to their first-quarter sales figures.

  • Subscriber Content Read Preview

    [HIVTRIAL]

    Trial Halted on HIV Pill for Women

    A trial to determine whether AIDS drugs taken by mouth can ward off HIV infection in women has been stopped early, a setback that surprised researchers after a string of successes in preventing transmission of the disease.

  • Off-Label Use of Clot Drug Is Faulted

    The use of a drug for the rare blood disorder hemophilia has soared in hospitals in the U.S. in the last decade, but nearly all of the growth has come from treatment of medical conditions for which the medicine has little proven benefit, researchers said.

  • Subscriber Content Read Preview

    [TENET]

    Community Health Revises Tenet Bid

    Community Health Systems converted its roughly $3.3 billion bid for Tenet Health to all-cash, the latest salvo in the hospital operator's hostile pursuit of its smaller rival.

  • Subscriber Content Read Preview

    [JNJ]

    Synthes Is Seen as a Fit for J&J;

    A potential $20 billion medical-device deal with Synthes would be Johnson & Johnson's biggest-ever acquisition and reinvigorate its struggling device business.

  • Subscriber Content Read Preview

    J&J; in Talks to Buy Synthes

    Johnson & Johnson is in talks to buy U.S.-Swiss medical-equipment maker Synthes in a deal that could be valued at around $20 billion. The deal would rank as one of the biggest health-care takeovers in recent years.

  • Leukemia Drug Shortage May Get Relief

    An Illinois drug maker plans next week to resume shipments of a key leukemia drug, helping to alleviate a life-threatening shortage of the drug, although it won't immediately fix the problem.

  • Subscriber Content Read Preview

    New York Hunts for Audit Leak

    The New York Inspector General's office is investigating the leak of a state audit of a $1 billion home-care company, after a Journal article reported that state Medicaid auditors were investigating whether Visiting Nurse Service of New York over-billed the Medicaid program.

  • Board Forces Doctor to Seek Approval on Surgeries

    The Oregon Medical Board forced a neurosurgeon who performed multiple spinal fusions on the same patients to seek prior approval before doing any more surgeries, in a temporary step pending a full investigation.

  • Subscriber Content Read Preview

    Glaxo to Shed Its OTC Diet Drug, Alli

    Four years after launching the nonprescription diet pill Alli with much fanfare and a heavy marketing budget, U.K. drug maker GlaxoSmithKline said it plans to sell the drug along with a clutch of other over-the-counter brands.

  • Subscriber Content Read Preview

    White House Medicare Savings Outlined

    President Barack Obama outlined a plan to cut $480 billion by 2023 from the U.S. government's health-care programs for the elderly and poor, drawing a sharp line of disagreement with House Republican leaders over how to rein in the burgeoning costs of medical care.

  • [DRUGSHORT]

    Shortage of Leukemia Drug Worsens

    A shortage of a key leukemia drug that started last year has worsened, causing many major cancer centers such as the Johns Hopkins Hospital to start rationing the drug and others to turn away patients from community hospitals that have run out of the medication.

  • MS Study Questions Blocked-Vein Theory

    A new multiple-sclerosis study questions a theory about a potential cause for the autoimmune disease that had been embraced by patients around the world, who had turned to risky surgeries to unblock neck veins when drug treatments didn't work for them.

  • [OMEGA]

    Hospital Bars Surgeon From Operating Room

    A Portland, Ore., neurosurgeon who performed multiple spinal fusions on the same patients lost his operating privileges at the hospital where he did many of his surgeries and is under investigation by the Oregon Medical Board.

  • [brainslice0412]

    Scientists Unveil Atlas of the Brain

    The online atlas documents the interplay between brain structure and biochemistry, charting genes at work throughout the human brain.

  • Subscriber Content Read Preview

    Two Drugs for Cancer Get Boost

    An FDA advisory panel backed the use of two cancer drugs from Novartis and Pfizer to treat a rare type of pancreatic cancer.

  • Subscriber Content Read Preview

    Study Finds Some Resistance to Abbott's Humira

    A study found that more than one-fourth of rheumatoid arthritis patients developed resistance to Abbott's anti-inflammatory drug Humira.

  • [INFORMEDjp1]

    Get Moving to Ease Joint Pain

    As more young people are diagnosed with osteoarthritis, doctors are recommending physical activity to help joints over traditional advice to take it easy.

  • How Old Viruses May Haunt Us

    Recent studies suggest ancient viruses, which litter the human genome but were believed to lie dormant, may play a role in modern diseases like Hodgkin's lymphoma and multiple sclerosis.

  • Subscriber Content Read Preview

    Novartis Cancels Cancer Drug

    Novartis is discontinuing the development of its drug Tasigna as initial therapy for patients with a rare form of stomach cancer because it is unlikely the drug will work better than Gleevec, the current standard of care.

Health Blog

What's Your Workout

Research Health

Get in-depth research on Health companies, including complete news and financials, earnings estimates and more.

Follow Health News

Answers allows you to tap the knowledge of Community members. Answer a question below or ask a question.

Q: What resources do you use to select a doctor to treat someone in your family?

Top Groups In Health

  • Health Journal

    Health Journal columnist Melinda Beck discusses health-care questions with readers, sources and friends.

Partner Center
An Advertising Feature